NFE2L2 and lung cancer: Mutations resulting in gain of function of NRF2 [26,74] and loss of functions of KEAP1 resulting in higher levels of free NRF2 have been witnessed in NSCLC and mediate metastasis [74,75] and metabolic remodeling in lung cancer cells [76].